BMP-6 Polyclonal Antibody, 100ul[BT-AP00928] Enzymes The phenotype of malignant melanomas

The phenotype of malignant melanomas in vivo depends on the global expression of stimulatory or inhibitory factors generated in both the tumors cells and their environment

It is subject to negative-feedback regulation by U-PA which cleaves it into an inactive form

Langer-Saldino achondrogenesis

This gene encodes a DNA polymerase type-A family member

BMP-6 Polyclonal Antibody, 100ul[BT-AP00928] Enzymes The phenotype of malignant melanomasBMP6 (bone morphogenetic protein 6) encodes a secreted ligand of the TGF beta (transforming growth factor beta) superfamily of proteins. Ligands of this family bind various TGF beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide linked homodimer. This protein regulates a wide range of